FSSAI Announces New Lab To Test ‘Food For Sportspersons’ Products

New Delhi:  The Food Safety and Standards Authority of India (FSSAI) has announced the notification of an additional laboratory for testing “Food for Sportspersons” for prohibited substances as defined by the World Anti-Doping Agency (WADA). The newly designated laboratory is the Analytical Testing Laboratory at the National Institute of Pharmaceutical Education and Research (NIPER) located in Balanagar, Hyderabad, Telangana.

It is worth noting that FSSAI had recently appointed the Centre of Excellence for Research and Analysis of Narcotic Drugs and Psychotropic Substances (CERANS) as a laboratory for testing “Food for Sportspersons” for the same purpose. With the addition of the Analytical Testing Laboratory at NIPER, two laboratories have been designated for this task.

According to the FSS (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purposes, Functional Food, and Novel Food) Regulations, 2016, no prohibited substances identified by WADA should be included in any food products meant for sportspersons. Food business operators are required to consult the annual list of prohibited substances published by WADA, which is effective from January 1 each year.

The scope of accreditation for the laboratory is categorized as “Chemical.” The current accreditation granted by the National Accreditation Board for Testing and Calibration Laboratories (NABL) allows for testing of prohibited substances declared by WADA under the category of “Chemical-Nutritional Supplement.”

FSSAI has instructed enforcement authorities to utilise the newly notified laboratory for testing “Food for Sportspersons” with an FSSAI license for prohibited substances declared by WADA as needed.

Related Posts

National Pharmaceutical Pricing Authority notifies retail price of 42 new drugs

New Delhi:  The National Pharmaceutical Pricing Authority (NPPA) has notified retail price of 42 new drugs under the provisions of the Drugs Prices Control Order (DPCO), 2013, including anti hypertensive,…

World’s First Malaria Treatment for Newborns and Young Infants Receives WHO Prequalification

New Delhi– In a landmark development for global child health, the World Health Organization (WHO) has granted prequalification to Coartem® Baby (artemether-lumefantrine), the first and only antimalarial medicine specifically developed…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

National Pharmaceutical Pricing Authority notifies retail price of 42 new drugs

National Pharmaceutical Pricing Authority notifies retail price of 42 new drugs

World’s First Malaria Treatment for Newborns and Young Infants Receives WHO Prequalification

World’s First Malaria Treatment for Newborns and Young Infants Receives WHO Prequalification

FIR Lodged Against Pharmacist in Chandauli for Working Nearly 10 Years on Forged Documents

FIR Lodged Against Pharmacist in Chandauli for Working Nearly 10 Years on Forged Documents

Laughing all the Way to Health with Sir Ganga Ram Hospital

Laughing all the Way to Health with Sir Ganga Ram Hospital

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Pak-made illegal cosmetics recovered from Itwari shop

Pak-made illegal cosmetics recovered from Itwari shop